SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Innerdyne -- Why are they still losing money?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter who wrote (2)5/16/1997 10:32:00 PM
From: Charles W. Breaux, Jr.   of 68
 
I'm a pediatric surgeon, and I use their stuff. Abdominal surgery is increasingly performed laparoscopically. The abdominal cavity is entered with trocars, 2-12 mm diameter tubes, through which the scope & instruments are passed. Complications with laparoscopic surgery come most frequently with trocar insertion (eg, bleeding from abdominal wall vessels or deep vessels, bowel perforation). With the trocars from most companies, a sharp triangular point must be pushed into the abdomen with force. IDYN has the Step system, a proprietary radially dilating technology; a thin expandable mesh tube is placed through the abdominal wall with a blunt tip & then dilated up to the appropriate size port with an inner dilator, spreading but not cutting the tissue. Most surgeons, when they are introduced to the Step system from IDYN, think it's neat. After they use it, they're hooked. I know I wouldn't go back.

The next quarter is supposed to be the first profitable one for the company. I'm in at $2 & hoping for steady gains with the next quarter on out. The IDYN sales reps say their bosses are thinking $7 in the next couple of years.

Chuck.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext